From Satiety to Reward Reshaping: Central Mechanisms of GLP-1 Receptor Agonists and Therapeutic Implications for Reward-related Disorders
Yun Liu, Yu Zhi, WingYi Ng, Jiahui Xie, Yujue Wang, Guanhu Yang, Bin Xu, Tiancheng Xu
Nanjing University of Chinese Medicine Macau University of Science and Technology Ohio University Schweizerisches Universitäres Institut für Traditionelle Chinesische Medizin
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
The classical theory of glucagon-like peptide-1 receptor agonists (GLP-1RAs) emphasizes peripheral metabolic regulation and satiety mediated by hypothalamic-brainstem homeostatic pathways. However, numerous clinical studies have shown that GLP-1RAs significantly suppress patients' food cravings and simultaneously reduce cravings for non-food reinforcers such as alcohol and nicotine, suggesting that the effects of GLP-1RAs extend far beyond the regulation of energy balance. GLP-1 receptors are expressed in the ventral tegmental area, the nucleus accumbens, and the central amygdala; their activation exhibits phase-specific effects: during the reward anticipation phase, they reduce dopamine signaling in the nucleus accumbens, whereas during the intake phase, they enhance this signaling. GLP-1RAs can modulate the mesolimbic dopamine system, likely through a combination of direct central actions and indirect peripheral- to-central signaling pathways, dynamically modulating reward processing rather than simply inhibiting it. Given that the mesolimbic dopamine system serves as a common neural substrate for both food and drug addiction, the observed modulatory effects of GLP-1RAs on various reinforcers suggest preliminary potential for expanded application in the treatment of binge eating disorder and substance use disorders, although clinical evidence remains limited for most non-food indications. Future research should elucidate the central penetration characteristics of different agonists, their cell-type-specific mechanisms of action, and the persistence of their neuromodulatory effects to advance the development of precision therapeutic strategies targeting specific reward circuits.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Neurotransmitter Receptor Influence on Behavior
Regulation of Appetite and Obesity · Diabetes Treatment and Management